Medical technology assessment--intended for whom?
作者信息
Mariner W K
出版信息
Am J Public Health. 1993 Nov;83(11):1525-6. doi: 10.2105/ajph.83.11.1525.
Abstract
摘要
相似文献
1
Medical technology assessment--intended for whom?
Am J Public Health. 1993 Nov;83(11):1525-6. doi: 10.2105/ajph.83.11.1525.
2
Medical technology assessment and practice guidelines: their day in court.医疗技术评估与实践指南：它们在法庭上的情况。
Am J Public Health. 1993 Nov;83(11):1635-9. doi: 10.2105/ajph.83.11.1635.
3
Reimbursing new technologies: why are the courts judging experimental medicine?新技术的报销问题：为何法院要对实验性医学进行评判？
Stanford Law Rev. 1992 May;44(5):1095-131.
4
Medical insurance payments and patients involved in research.
IRB. 1994 Jan-Apr;16(1-2):19-22.
5
What is the method to their "madness?" Experimental treatment exclusions in health insurance policies.
J Contemp Health Law Policy. 1997 Spring;13(2):613-36.
6
Emerging technologies and medical coverage.
Clin Ethics Rep. 1996 Spring-Summer;10(1):9-12.
7
Undefined experimental treatment exclusions in health insurance contracts: a proposal for judicial response.
Wash Law Rev. 1991 Jul;66(3):809-30.
8
9
Emerging technology. Patient protection versus proliferation. Symposium.
J Clin Gastroenterol. 1987 Jun;9(3):258-73.
10
Antitrust implications of medical technology assessment.
N Engl J Med. 1986 Jun 5;314(23):1490-3. doi: 10.1056/NEJM198606053142306.
Zotero 插件